Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Edward H. Blaine"'
Autor:
Edward H. Blaine, William E. Dale
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 77:763-769
Our objective was to determine if the ability of an angiotensin-converting enzyme (ACE) inhibitor to attenuate neointima formation in balloon-damaged vessel is expressed in an isolated organ culture model of neointimal growth. In vivo balloon angiopl
Autor:
Maria A. Palomo, Gillian M. Olins, Ellen G. Mcmahon, Timothy S. Chamberlain, Susan T. Chen, Robert E. Manning, Edward H. Blaine, Horng-Chih Huang, Valerie M. Corpus
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:2591-2596
A series of potent, selective, conformationally restricted angiotensin II (AII) receptor antagonists has been discovered. Two classes of conformationally restricted analogues were prepared: triazolone-based and imidazole-based biphenyl derivatives. T
Publikováno v:
Scopus-Elsevier
To determine the relative influence of current exercise and diet on the late-life cognitive health of former Division I collision-sport collegiate athletes (ie, football players) compared with noncollision-sport athletes and non-athletes.Graduates (n
Autor:
Glenn J. Smits, Robert E. Manning, David B. Reitz, Edward H. Blaine, J P Koepke, Gillian M. Olins, Horng-Chih Huang
Publikováno v:
American Journal of Hypertension. 6:619-625
The depressor activity of a novel nonpeptidic angiotensin II (AII) receptor antagonist, SC-51316 (2,5-dibutyl-2,4-dihydro-4-[[2-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4 '- yl]-methyl]-3H-1,2,4-triazol-3-one), is described. In anesthetized, ganglion-blocke
Autor:
Edward H. Blaine, Ellen G. Mcmahon
Publikováno v:
Current Opinion in Cardiology. 6:686-692
Autor:
Kerry L. Spear, Gillian M. Olins, Philippe R. Bovy, Edward H. Blaine, Larry D. Tyler, Pramod P. Mehta, J P Koepke, Dale A. Hartupee, Angelo J. Trapani
Publikováno v:
American Journal of Hypertension. 3:622-627
We examined the interaction of a non-guanylate cyclase-linked atriopeptin (AP) binding site ligand, SC-46542 (des[Phe106,Gly107,Ala115,Gln116]AP-(103-126], and an endopeptidase 24.11 inhibitor, thiorphan, on mean arterial pressure, urinary sodium exc
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 258:H1427-H1431
In vitro studies have suggested that atrial natriuretic peptide (ANP) is a potent antagonist of the vasoconstrictor actions of angiotensin II (ANG II). The purpose of this study was to determine the long-term effects of physiological increases in cir
Autor:
Edward H. Blaine
Publikováno v:
Hypertension. 15:2-8
Atrial natriuretic factor (ANF) is a hormone with the physiological characteristics of a regulator of body fluid volume. It is potent, has a short duration of action, and responds to a physiologically relevant stimulus in a negative feedback-controll
Publikováno v:
Hypertension. 57:1-2
James Othello Davis, MD, PhD, an outstanding scientist who made many exceptional contributions to the advancement of biomedical research in his lifetime, was born July 12, 1916 in Tahlequah, Oklahoma and died September 28, 2010 in St. Louis, Missouri
Autor:
Kathleen S. Curtis, J. Thomas Cunningham, Eileen M. Hasser, Edward H. Blaine, Margaret J. Sullivan, Meredith Hay
Publikováno v:
Clinical and experimental pharmacologyphysiology. 27(5-6)
1. Precise control over the cardiovascular system requires the integration of both neural and humoral signals related to blood volume and blood pressure. Humoral signals interact with neural systems, modulating their control over the efferent mechani